Definitive Radiation for High-Risk Spine Metastases
- Conditions
- Metastatic TumorMetastatic Breast CancerSpine MetastasesMetastatic CancerMetastatic Lung CancerMetastatic Tumor to the SpineMetastatic Tumor of BoneMetastasis
- Registration Number
- NCT06165419
- Lead Sponsor
- Stony Brook University
- Brief Summary
This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 26
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT 6 months Assess the efficacy of spine SBRT alone in controlling spine metastases
- Secondary Outcome Measures
Name Time Method Progression-free survival 6 months Changes on EuroQol 5 Dimensions 5 Levels (EQ-5D-5L) questionnaire 1 months, 3 months, 6 months The EuroQol 5D-5L questionnaire measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each health dimension is scored from 1 to 5, with 1 indicating a better health state, and 5 the worse state possible. Respondents also indicate their overall health status on visual analogue score, with values ranging from 0 (worst health imaginable) to 100 (best health imaginable)
Changes on Oswestry Low Back Disability Questionnaire 1 months, 3 months, 6 months The Oswestry Disability Index measures disability in patients with low back pain, with scores varying from 0 to 50. Lower scores indicate better outcomes, higher scores indicate a worse outcome.
Changes on Neck Disability index 1 months, 3 months, 6 months The Neck Disability Index measures neck pain and disabilities in patients with neck pain, with scores varying from 0 to 50. Lower scores indicate better outcomes, higher scores indicate a worse outcome.
Reduction in epidural tumor volume 3 months Percent reduction of epidural volume of the treated metastatic lesions
Overall survival 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Stony Brook University Hospital
🇺🇸Stony Brook, New York, United States
Stony Brook University Hospital🇺🇸Stony Brook, New York, United StatesCaterina Vacchi-Suzzi, PhDContact631-216-2993caterina.vacchi-suzzi@stonybrookmedicine.edu